Antimicrobial Resistance News and Research

RSS

BioFire Diagnostics' FilmArray Blood Culture Identification Panel receives CE IVD Mark

BioFire Diagnostics, Inc. announced today that it obtained the CE IVD Mark under the European Directive on In Vitro Diagnostic Medical Devices for its FilmArray Blood Culture Identification Panel.

6 Jun 2013

Duke University is awarded $2M to initiate new clinical research network on antibacterial resistance

Duke University, Durham, N.C., has been awarded $2 million to initiate a new clinical research network focused on antibacterial resistance. Total funding for the leadership group cooperative agreement award could reach up to $62 million through 2019.

4 Jun 2013

U.S. on the verge of potentially devastating epidemic of untreatable gonorrhea

Gonorrhea has long been one of the most commonly-reported sexually transmitted diseases (STDs) in the U.S. and, unfortunately, with rising antimicrobial resistance, it has also become one of the most frightening for public health.

24 Apr 2013

Unnecessary use of antibiotics in elderly women in EDs increases risk of unintended consequences

Older adults represent an important and growing demographic in emergency departments across the country, with urinary tract infections being one of the leading causes for ED visits.

23 Apr 2013

Texas scientist says nonmedical community should be educated about long-term effects of antibiotic overuse and misuse

When thousands of experimental biology researchers gather in Boston this weekend, many of them undoubtedly will be presenting work related to the hunt for the next generation of antibiotics and how to battle back existing and emerging superbugs.

22 Apr 2013

Time dwindling to meet IDSA goal of 10 new antibiotics by 2020

Despite the desperate need for new antibiotics to combat increasingly deadly resistant bacteria, the U.S. Food and Drug Administration (FDA) has approved only one new systemic antibiotic since the Infectious Diseases Society of America (IDSA) launched its 10 x '20 Initiative in 2010 - and that drug was approved two and a half years ago.

22 Apr 2013

Erythromycin may provide benefit for patients with non-CF bronchiectasis

Among patients with the lung disorder non-cystic fibrosis bronchiectasis, treatment with the antibiotic erythromycin resulted in improvement in symptoms but also increased the risk of antibiotic resistance, according to a study appearing in the March 27 issue of JAMA.

27 Mar 2013

Inadequate health literacy among Latinos linked with poor understanding of antibiotic use

In the first study of its kind, researchers at the Columbia University School of Nursing have established that poor health literacy among Latino parents is associated with a poor understanding of the proper use antibiotics, particularly for upper respiratory infections (URIs), which can lead to an increase in antimicrobial resistance.

2 Feb 2013

Less is more when it comes to antibiotics for UTI in men

Research suggests that standard antibiotic prescribing for urinary tract infections in male patients may need to be reviewed, as currently recommended 7–14-day courses appear to be no more effective than shorter ones, and may increase the risk for antimicrobial resistant or Clostridium difficile infection.

17 Dec 2012

Top-line results from Durata Therapeutics’ dalbavancin Phase 3 study on ABSSSI

Durata Therapeutics, Inc. today announced preliminary, top-line results for its DISCOVER 1 ("Dalbavancin for Infections of the Skin COmpared to Vancomycin at an Early Response") Phase 3 study of dalbavancin, which is under investigation for the treatment of acute bacterial skin and skin structure infections (ABSSSI) caused by susceptible gram-positive bacteria, including MRSA (methicillin resistant Staphylococcus aureus).

11 Dec 2012

Less is more when it comes to antibiotics for UTI in men

6 Dec 2012

Metalloacid surfaces may be answer to hospital-acquired infections

Coating surfaces in metalloacids may help control the spread of hospital-acquired infections, suggest study findings.

14 Nov 2012

Key areas of disease neglected by UK funding for infectious diseases

UK funding for infectious diseases research is neglecting some of the diseases that result in the highest rates of death and disability, according to an Article published Online First in The Lancet Infectious Diseases.

8 Nov 2012

Microgravity and prolonged space flight could give unique advantages to germs

The cabin of a spacecraft halfway to Mars would be the least convenient place -- one cannot say "on earth" -- for a Salmonella or Pneumococcus outbreak, but a wide-ranging new paper suggests that microgravity and prolonged space flight could give unique advantages to germs.

22 Oct 2012

Regional, seasonal variation in US antibiotic use highlights persisting issue

US study results reveal “substantial” quarterly and regional variation in outpatient antibiotic use among older adults, indicating the possible need for targeted programs to reduce unnecessary prescriptions.

1 Oct 2012

New class of chemically produced antimicrobial agents could become future infection treatment alternative

The World Health Organization (WHO) has named antimicrobial resistance one of the most important threats to human health. We therefore need to find new compounds that can be used as future alternatives to conventional antibiotics.

20 Jul 2012

EU-funded researchers develop new antimicrobial resistance monitoring solution

Every year hundreds of thousands of people die because of infections that have become resistant to treatment. A new data-mining, clinical monitoring and decision-support system, developed by EU-funded researchers, offers a powerful new weapon in the war on resistance to antibiotics.

14 Jul 2012

Secrets to the Danish success in combating antimicrobial resistance

The global consumption of antimicrobial agents for animals is almost twice the size of human consumption. Since the mid-1990s, Denmark has reduced animal consumption of antimicrobial agents by 60% without reducing its agricultural output. In a comment in the journal Nature, Professor Frank Møller Aarestrup, the National Food Institute, Technical University of Denmark, gives his explanation of the success of the Danish efforts.

2 Jul 2012

Hospira releases enhancement to TheraDoc clinical surveillance system

Hospira, the world's leading provider of injectable drugs and infusion technologies, today released an important enhancement to its TheraDoc clinical surveillance system designed to support hospital antimicrobial stewardship efforts, with the goal of helping to improve patient outcomes, reduce antimicrobial resistant infections and reduce costs.

11 Jun 2012

WHO calls for greater vigilance on correct use of antibiotics against gonorrhoea

Millions of people with gonorrhoea may be at risk of running out of treatment options unless urgent action is taken, according to WHO. Already several countries, including Australia, France, Japan, Norway, Sweden and the United Kingdom are reporting cases of resistance to cephalosporin antibiotics - the last treatment option against gonorrhoea. Every year an estimated 106 million people are infected with gonorrhea, which is transmitted sexually.

7 Jun 2012